With 6 FDA-approved drugs and another 6 compounds in late stage preclinical development or clinical trials, Southern Research's track record in early drug discovery continues to grow. In addition, Southern Research has tested more than 80 percent of all other FDA approved cancer drugs and approximately 75 percent of all FDA approved anti-viral drugs.
You may also download a printable version (1.5 MB) of this chart in Acrobat PDF format.